Boustani J - Search Results

1

Chemotherapy to potentiate the radiation-induced immune response.

Lecoester B, Wespiser M, Marguier A, Mirjolet C, Boustani J, Adotévi O. Lecoester B, et al. Among authors: boustani j. Int Rev Cell Mol Biol. 2023;376:143-173. doi: 10.1016/bs.ircmb.2023.01.004. Epub 2023 Feb 11. Int Rev Cell Mol Biol. 2023. PMID: 36997268 Review.

2

The 6th R of Radiobiology: Reactivation of Anti-Tumor Immune Response.

Boustani J, Grapin M, Laurent PA, Apetoh L, Mirjolet C. Boustani J, et al. Cancers (Basel). 2019 Jun 20;11(6):860. doi: 10.3390/cancers11060860. Cancers (Basel). 2019. PMID: 31226866 Free PMC article. Review.

3

Quality Assurance of Dose-Escalated Radiation Therapy in a Randomized Trial for Locally Advanced Oesophageal cancer.

Boustani J, Rivin Del Campo E, Blanc J, Peiffert D, Benezery K, Pereira R, Rio E, Le Prisé E, Créhange G, Huguet F. Boustani J, et al. Int J Radiat Oncol Biol Phys. 2019 Oct 1;105(2):329-337. doi: 10.1016/j.ijrobp.2019.06.2542. Epub 2019 Jul 9. Int J Radiat Oncol Biol Phys. 2019. PMID: 31299242 Clinical Trial.

4

Radiotherapy Scheme Effect on PD-L1 Expression for Locally Advanced Rectal Cancer.

Boustani J, Derangère V, Bertaut A, Adotevi O, Morgand V, Charon-Barra C, Ghiringhelli F, Mirjolet C. Boustani J, et al. Cells. 2020 Sep 10;9(9):2071. doi: 10.3390/cells9092071. Cells. 2020. PMID: 32927784 Free PMC article.

5

Cisplatin-based chemoradiation decreases telomerase-specific CD4 TH1 response but increases immune suppressive cells in peripheral blood.

Boustani J, Joseph ELM, Martin E, Benhmida S, Lecoester B, Tochet F, Mirjolet C, Chevalier C, Thibouw D, Vulquin N, Servagi S, Sun X, Adotévi O. Boustani J, et al. BMC Immunol. 2021 Jun 18;22(1):38. doi: 10.1186/s12865-021-00429-5. BMC Immunol. 2021. PMID: 34144673 Free PMC article.

6

Chemoradiation triggers antitumor Th1 and tissue resident memory-polarized immune responses to improve immune checkpoint inhibitors therapy.

Lauret Marie Joseph E, Kirilovsky A, Lecoester B, El Sissy C, Boullerot L, Rangan L, Marguier A, Tochet F, Dosset M, Boustani J, Ravel P, Boidot R, Spehner L, Haicheur-Adjouri N, Marliot F, Pallandre JR, Bonnefoy F, Scripcariu V, Van den Eynde M, Cornillot E, Mirjolet C, Pages F, Adotevi O. Lauret Marie Joseph E, et al. Among authors: boustani j. J Immunother Cancer. 2021 Jul;9(7):e002256. doi: 10.1136/jitc-2020-002256. J Immunother Cancer. 2021. PMID: 34230108 Free PMC article.

7

Anti-PD-1/Anti-PD-L1 Drugs and Radiation Therapy: Combinations and Optimization Strategies.

Boustani J, Lecoester B, Baude J, Latour C, Adotevi O, Mirjolet C, Truc G. Boustani J, et al. Cancers (Basel). 2021 Sep 29;13(19):4893. doi: 10.3390/cancers13194893. Cancers (Basel). 2021. PMID: 34638376 Free PMC article. Review.

8

Contribution of chemotherapy in immunoradiotherapy combinations.

Xie Y, Lecoester B, Boustani J. Xie Y, et al. Among authors: boustani j. Cancer Radiother. 2023 Sep;27(6-7):519-523. doi: 10.1016/j.canrad.2023.06.015. Epub 2023 Jul 24. Cancer Radiother. 2023. PMID: 37495428 Review.

9

Evaluation of a 36 Gy elective node irradiation dose in anal cancer.

Lépinoy A, Lescut N, Puyraveau M, Caubet M, Boustani J, Lakkis Z, Fantoli M, Buffet-Miny J, Kim S, Bednarek C, Maingon P, Créhange G, Bosset JF. Lépinoy A, et al. Among authors: boustani j. Radiother Oncol. 2015 Aug;116(2):197-201. doi: 10.1016/j.radonc.2015.07.050. Epub 2015 Aug 12. Radiother Oncol. 2015. PMID: 26277433

10

Adjuvant Chemotherapy in Rectal Cancer after Chemoradiotherapy.

Boustani J, Caubet M, Bosset JF. Boustani J, et al. Clin Oncol (R Coll Radiol). 2016 Feb;28(2):140-145. doi: 10.1016/j.clon.2015.11.004. Epub 2015 Dec 14. Clin Oncol (R Coll Radiol). 2016. PMID: 26698026 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

28 results

Search Page